GREENVILLE, S.C., June 14,
2022 /PRNewswire/ -- Premier Medical Laboratory
Services (PMLS), a nation leading advanced medical diagnostics
lab, adds AditxtScore™ to its menu of testing services.
Providing more clarity regarding a patient's individual immunity
profile, AditxtScore™ allows patients to know their level of
protection that an immune response to the virus or vaccination has
provided them. Now that a large segment of the population has
either undergone vaccination or experienced a symptomatic or
asymptomatic infection with SARS-CoV-2, AditxtScoreä provides
information on immune status during the current phase of the
pandemic.
"As new variants emerge, we want to equip physicians with the
most advanced tests that allow a comprehensive view of their
patient's health status," said Kevin
Murdock, CEO of Premier Medical Laboratory Services. "With
AditxtScoreä, individuals can make more informed decisions about
whether vaccination, boosters, or other risk mitigation strategies
are the right course of action for them."
PMLS, a CAP Accredited laboratory which has processed over 3.5
million COVID-19 tests and houses one of the largest Next
Generation Sequencing variant tracing platforms in the country, has
set out to provide the most advanced solutions to combat COVID-19
over the last two years. While the virus continues to spread and
the implications of the new variants are unknown, it is vital that
transmission rates, severity of infection, and immunity trends are
monitored. AditxtScoreä can be used routinely to identify changes
in immune response over time and contribute greatly to the
continued understanding of responses to SARS-CoV-2. The test can
also provide needed information for individuals, and in certain
instances, may help to minimize vaccine hesitancy for those who are
not protected by antibodies.
AditxtScoreä results provide answers to the following
questions for an individual:
- Does the individual have antibodies present?
- Are the individual's antibodies present as a result of
vaccination or from an immune response to infection by the
virus?
- Is the individual's immune response likely to provide
protection against future infection?
- What are possible ways to minimize risk of a future infection
(e.g. boosting or limiting exposure)?
With a blood draw, AditxtScore™ provides an assessment
of multiple antibody types against multiple
SARS-CoV-2 antigens. AditxtScoreä also measures levels of
neutralizing antibodies, which block viral entry into human cells.
A proprietary algorithm is utilized to assess and translate
clinical data into meaningful information for individuals.
Interpretive information about results and possible ways to
minimize risk are then provided to the patient. Developed at the
CLIA-certified, CAP-accredited AditxtScore™ Center, led by lab
scientists trained at prestigious institutions such as Mayo Clinic
and Stanford University, the test is
comprehensive and accurate.
In addition to further clarity that an individual can gain
regarding their own immunity profile, employers can utilize
AditxtScoreä to save time and money with their COVID-19
testing efforts by managing the frequency of testing. The test
can also help to minimize lost time and wages for employees
with less frequent quarantines. Lastly, it can keep employees safer
by identifying those employees most at risk of infection.
AditxtScore™ is offered through Premier Medical
Laboratory Services as an authorized channel partner. Additional
terms, conditions and restrictions may apply. Please click on the
following link for further information
https://premedinc.com/aditxtscore-immune/
About PMLS
Premier Medical Laboratory Services (PMLS), headquartered in
Greenville, South Carolina, is the
official health and wellness partner of the Greenville Triumph and
an advanced molecular diagnostics lab fully certified by top
laboratory accrediting organizations, including CLIA and COLA. PMLS
prides itself on delivering some of the most rapid turnaround times
of testing results in the industry and patient friendly billing.
Their expansive menu of highly advanced tests and screenings
include genomic risk assessment assays for various cancers, heart
disease, and diabetes, as well as women's health panels,
toxicology, allergy testing, pharmacogenomics, routine blood
chemistry, and noninvasive prenatal testing (NIPT). With a
heartfelt mission to improve patient care, their in-house research
and development team of PhD scientists and forward-thinking
laboratory staff are continually innovating ways to provide the
most highly advanced medical diagnostics available. For more
information about PMLS, please visit www.premedinc.com or call
866.312.4707.
About Aditxt
Aditxt (NASDAQ: ADTX) is a biotech innovation company developing
and commercializing technologies focused on monitoring and
reprogramming the immune system. Aditxt's immune monitoring
technologies are designed to provide a personalized immune profile.
Aditxt's immune reprogramming technologies, currently preclinical,
are being developed to retrain the immune system to induce
tolerance to address rejection of transplanted organs, autoimmune
diseases, and allergies.
For more information, please visit: www.aditxt.com and
www.AditxtScore.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/premier-medical-laboratory-services-now-offering-aditxtscore-personalized-immune-test-for-covid-19-301567874.html
SOURCE Premier Medical Laboratory Services